title: Pseudohypopyon: Extramedullary relapse of acute myelogenous leukemia with poor prognosis.
abstract: An 11-month-old female presented to the emergency department with a 2-week history of fever, increasing fussiness, emesis, and decreased urine output. She was diagnosed with acute myelogenous leukemia. Systemic chemotherapy with intensified intrathecal cytarabine was started, and the patient achieved a clinical remission after the first course of induction. Towards the end of her second course of induction she developed pseudohypopyon in each eye on consecutive days, heralding a central nervous system relapse.
authors.affiliation: Department of Pediatrics, The Children's Hospital, University of Colorado Denver School of Medicine, Aurora, Colorado 80045, USA.
authors.forename: William C
authors.initials: WC
authors.lastname: Petersen
authors.forename: Krysta D
authors.initials: KD
authors.lastname: Schlis
authors.forename: Rebecca S
authors.initials: RS
authors.lastname: Braverman
authors.forename: Ingrid
authors.initials: I
authors.lastname: Carlson
authors.forename: Xiayuan
authors.initials: X
authors.lastname: Liang
authors.forename: Michael
authors.initials: M
authors.lastname: Wang
mesh_terms: D000867:Anterior Chamber / Q000473:pathology*; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D005128:Eye Diseases / Q000175:diagnosis*; D005260:Female; D006801:Humans; D007223:Infant; D007278:Injections, Spinal; D015479:Leukemia, Myelomonocytic, Acute / Q000175:diagnosis* / Q000188:drug therapy; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000628:therapy; D011379:Prognosis; D013492:Suppuration / Q000175:diagnosis
chemical_list: D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine